Cantourage Group SE

News

27.01.2025 09:01:01
Original-Research: Cantourage Group SE (von NuWays AG): Buy
15.01.2025 07:30:09
EQS-News: Legalization of cannabis brings strong growth: Cantourage Group SE increases its sales by 118% to EUR 51.4 million in full year 2024
20.12.2024 09:01:02
Original-Research: Cantourage Group SE (von NuWays AG): Buy
19.12.2024 08:00:19
EQS-News: Cantourage Group SE exports medical craft cannabis for the first time to the growth market of Poland; cooperation with the wholesaler PharmaVitae to be expanded in 2025
06.12.2024 09:01:01
Original-Research: Cantourage Group SE (von NuWays AG): BUY
20.11.2024 08:00:21
EQS-News: New Sales Record: Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets
07.11.2024 08:00:16
EQS-News: Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth
10.10.2024 09:02:11
Original-Research: Cantourage Group SE (von NuWays AG): Buy
10.10.2024 08:00:20
EQS-News: The medical cannabis market is booming: Cantourage Group SE reports record quarter in third quarter of 2024
05.09.2024 09:02:13
Original-Research: Cantourage Group SE (von NuWays AG): Buy

Downloads

Latest Research
Initiation

Analyst

Christian Sandherr

Equity Research

MailLinkedIn

Latest Research

Christian Sandherr

27 Jan 25

FY24 with explosive growth // new high(t)s in sight; PT Up

Update
Christian Sandherr

20 Dec 24

Cantourage entering the Polish market; PT up

Update
Christian Sandherr

06 Dec 24

Full steam ahead, FY24 guidance raised; PT up

Update
Christian Sandherr

10 Oct 24

9M prelims: Growth further accelerating, FY guidance specified

Preview / Review
Christian Sandherr

05 Sep 24

FY24 guidance issued, growth to remain stellar

Update

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.